AI Metrics is a start-up company based in Birmingham, Alabama and founded by radiologist Dr. Andrew Smith.
To leverage artificial intelligence and innovative imaging software solutions to improve workflows, quantitative metrics, and reporting in clinical practice and clinical trials.
Globally transform medical imaging and redefine the standard of care by realizing the full potential of artificial intelligence in imaging metrics.
Current Technology Development
AI Metrics is developing medical imaging software tools that utilize artificial intelligence to improve complex workflows, extract quantitative metrics, and provide standardized reports.
Exciting new products and updates coming soon. Sign up for updates!
Liver Surface Nodularity
CT is used routinely in the diagnosis and management of chronic liver disease. As the disease progresses, bands of liver fibrosis form in reaction to chronic inflammation in the liver, transitioning over time into cirrhosis. With later stages of the disease, these changes in the liver can result in portal hypertension, associated side-effects, and eventually, to death. Improved staging of chronic liver disease is vital to choosing appropriate treatment plans and monitoring response in individual patients.
The appearance of liver surface nodularity on CT images is an important indicator of late-stage fibrosis and cirrhosis*, with increasing nodularity occurring with later stages of the disease. LSN helps standardize the evaluation of nodularity with interactive analysis tools and quantitative metrics, facilitating communications with colleagues and follow-up of a patient over time.
*ACR Appropriateness Criteria for Chronic Liver Disease
LSN Potential Uses:
Staging liver fibrosis
Predicting clinically significant portal hypertension
Predicting liver decompensation
Predicting death from cirrhosis
Launches from OsiriX plugin menu
Familiar tools for selecting regions of nodularity
Guided workflow for streamlined analysis
Encapsulated PDF summary reports
The Liver Surface Nodularity (LSN) software is now available as an OsiriX MD plugin. The LSN plugin may be used with CT images from any scanner or vendor and is validated for a wide range of clinical protocols, including both non-enhanced and contrast-enhanced images.
The OsiriX LSN software is not yet available for clinical use outside of an IRB-approved research protocol. FDA submission is planned for early 2020.
Demonstrated to dramatically improve radiologists’ workflow efficiency
0% Reporting Errors
Compared to 30% in current standard-of-care